1. Home
  2. VYNE vs AP Comparison

VYNE vs AP Comparison

Compare VYNE & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • AP
  • Stock Information
  • Founded
  • VYNE 2003
  • AP 1929
  • Country
  • VYNE United States
  • AP United States
  • Employees
  • VYNE N/A
  • AP N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • AP Fluid Controls
  • Sector
  • VYNE Health Care
  • AP Industrials
  • Exchange
  • VYNE Nasdaq
  • AP Nasdaq
  • Market Cap
  • VYNE 41.9M
  • AP 38.8M
  • IPO Year
  • VYNE 2018
  • AP N/A
  • Fundamental
  • Price
  • VYNE $2.98
  • AP $1.71
  • Analyst Decision
  • VYNE Strong Buy
  • AP
  • Analyst Count
  • VYNE 2
  • AP 0
  • Target Price
  • VYNE $6.88
  • AP N/A
  • AVG Volume (30 Days)
  • VYNE 122.3K
  • AP 53.8K
  • Earning Date
  • VYNE 11-07-2024
  • AP 11-12-2024
  • Dividend Yield
  • VYNE N/A
  • AP N/A
  • EPS Growth
  • VYNE N/A
  • AP N/A
  • EPS
  • VYNE N/A
  • AP N/A
  • Revenue
  • VYNE $493,000.00
  • AP $425,477,000.00
  • Revenue This Year
  • VYNE $32.31
  • AP N/A
  • Revenue Next Year
  • VYNE N/A
  • AP N/A
  • P/E Ratio
  • VYNE N/A
  • AP N/A
  • Revenue Growth
  • VYNE 39.27
  • AP 4.34
  • 52 Week Low
  • VYNE $1.57
  • AP $0.74
  • 52 Week High
  • VYNE $4.09
  • AP $2.89
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 59.02
  • AP 45.95
  • Support Level
  • VYNE $2.65
  • AP $1.61
  • Resistance Level
  • VYNE $3.05
  • AP $1.76
  • Average True Range (ATR)
  • VYNE 0.23
  • AP 0.13
  • MACD
  • VYNE -0.05
  • AP -0.01
  • Stochastic Oscillator
  • VYNE 34.57
  • AP 30.95

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is a U.S.-based company manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: